Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD.

Ronald de WitStephen J FreedlandStephane OudardGeorgi MarinovPhilippe CapartAustin J CombestRyan PetersonAyse OzatilganAlicia K Morgans

Published in: Prostate cancer and prostatic diseases (2022)

Sequential use of ARTA was frequent. Results indicate the CARD population is reflective of routine clinical practice and duration of response to cabazitaxel was similar in a real-world population.

Keyphrases

clinical practice
double blind
clinical trial
phase iii
randomized controlled trial
newly diagnosed
study protocol